Overview
Background
Prof Michael Barras is the Director of Pharmacy at the Princess Alexandra Hospital and a Research conjoint with the School of Pharmacy (Hospital 0.8 FTE / UQ 0.2 FTE). He currently supervises 8 HDR students who are conducting research related to medication safety, health informatics and advanced scope clinical pharmacy. He has a strong interest in designing, testing and monitoring individualised dosing strategies for high-risk patients in the hospital setting. Michael has many significant research relationships in hospital, university, and industry settings. He is a member of the SoP research committee.
Availability
- Professor Michael Barras is:
- Not available for supervision
Works
Search Professor Michael Barras’s works on UQ eSpace
2012
Journal Article
Gentamicin use - more clinical outcome evidence needed
Martin, Jennifer, Norris, Ross and Barras, Michael (2012). Gentamicin use - more clinical outcome evidence needed. Journal of Clinical Toxicology, 2 (6), e110.1-e110.2. doi: 10.4172/2161-0495.1000e110
2012
Journal Article
Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial
Martin, Jennifer, Barras, Michael, Yui, Nicholas Ah, Kirkpatrick, Carl, Kubler, Paul and Norris, Ross (2012). Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. Journal of Clinical Toxicology, 2 (8), 146.1-146.5. doi: 10.4172/2161-0495.1000146
2011
Journal Article
Recurrent readmissions in medical patients: A prospective study
Mudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811
2011
Conference Publication
Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis
Norris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba
2011
Journal Article
Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis
Barras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x
2010
Journal Article
Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development
Norris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a
2010
Journal Article
Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations
Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846
2010
Journal Article
Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey
Barras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x
2010
Journal Article
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Martin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24.
2010
Journal Article
Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins
Al-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000
2009
Other Outputs
Dose individualisation of enoxaparin
Michael Barras (2009). Dose individualisation of enoxaparin. PhD Thesis, Pharmacy school, The University of Queensland.
2009
Conference Publication
The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease
O’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043
2009
Journal Article
Myalgia in patients on high-dose and low-to-moderate dose statin therapy
Gujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x
2009
Book Chapter
Dose individualization of drugs based on body composition
Barras, Michael and Green, Bruce (2009). Dose individualization of drugs based on body composition. Heart disease in men. (pp. 219-242) edited by Alice B. Todd and Margo H. Mosley. New York, NY, United States: Nova Science Publishers.
2009
Journal Article
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x
2009
Journal Article
Preliminary results of a therapeutic drug monitoring survey in Australasia
Norris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71. doi: 10.1097/01268031-200941001-00167
2009
Conference Publication
A survey of therapeutic drug monitoring in Australasia
Norris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, 3-8 October 2009. New York, NY, U.S.A.: Lippincott-Raven. doi: 10.1097/FTD.0b013e3181b7997b
2008
Journal Article
Individualized compared with conventional dosing of enoxaparin
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399
2008
Journal Article
Individualised vs conventional enoxaparin dosing
Barras, Michael A. and Green, Bruce (2008). Individualised vs conventional enoxaparin dosing. Journal of Pharmacy Practice and Research, 38 (1), 77-81. doi: 10.1002/j.2055-2335.2008.tb00803.x
2008
Conference Publication
The evaluation of an individualised dosing strategy derived from population PK modelling and simulation
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy derived from population PK modelling and simulation. Population Approach Group in Australia and New Zealand (PAGANZ) Conference, Dunedin, Otago, New Zealand, 13-15 February 2008.
Supervision
Availability
- Professor Michael Barras is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
A pharmacist to improve medication management and patient outcomes for critically ill patients in the emergency department.
Principal Advisor
-
Doctor Philosophy
Patient-Centred Pharmacy Care in the hospital setting
Principal Advisor
Other advisors: Professor Ian Coombes
-
Doctor Philosophy
A predictive model for 30-day hospital readmission in Cardiology patients
Associate Advisor
Other advisors: Professor Ian Coombes
-
Doctor Philosophy
Voluntary assisted dying services in Queensland
Associate Advisor
Other advisors: Associate Professor Adam La Caze
-
Doctor Philosophy
Development and Integration of a Medication Harm Prediction Tool within an Australian Digital Hospital
Associate Advisor
Other advisors: Professor Ian Scott
-
Doctor Philosophy
Implementing a Medication review pharmacy clinic and the potential impact on patient care.
Associate Advisor
Other advisors: Dr Centaine Snoswell, Dr Holly Foot
-
Master Philosophy
Pharmacist led post discharge medication review in patients at high-risk of medication related harm
Associate Advisor
Other advisors: Dr Carla Scuderi, Professor Ian Coombes
-
Doctor Philosophy
A predictive model for 30-day hospital readmission in Cardiology patients
Associate Advisor
Other advisors: Professor Ian Coombes
-
Doctor Philosophy
Development and Integration of a Medication Harm Prediction Tool within an Australian Digital Hospital
Associate Advisor
Other advisors: Professor Ian Scott
-
Doctor Philosophy
Quality and Safe Use of Clozapine
Associate Advisor
Other advisors: Associate Professor Nicola Warren, Professor Steve Kisely, Professor Dan Siskind
-
Doctor Philosophy
Quality and Safe Use of Clozapine
Associate Advisor
Other advisors: Associate Professor Nicola Warren, Professor Steve Kisely, Professor Dan Siskind
-
Master Philosophy
Pharmacist led post discharge medication review in patients at high-risk of medication related harm
Associate Advisor
Other advisors: Professor Ian Coombes
Completed supervision
-
2024
Doctor Philosophy
Exploring the impact of electronic medication management on the safety and quality of therapeutic anticoagulation
Principal Advisor
Other advisors: Professor Clair Sullivan, Dr Lee Woods
-
2024
Doctor Philosophy
Medication harm in patients after acute myocardial infarction
Principal Advisor
Other advisors: Professor Ian Coombes
-
2022
Doctor Philosophy
Cellular studies on the role of matrix dependent mechanism of atherosclerosis: role of transcription factor Smad and its phosphorylation
Associate Advisor
-
2022
Doctor Philosophy
Aspirin for the Prophylaxis of Venous Thromboembolic Events
Associate Advisor
-
2020
Doctor Philosophy
Prioritising patients at high-risk of medication harm: Development and validation of risk prediction models
Associate Advisor
-
2017
Doctor Philosophy
Investigating the effectiveness of communication taking place between hospital pharmacists and patients during medication counselling
Associate Advisor
Other advisors: Honorary Professor Bernadette Watson
Media
Enquiries
For media enquiries about Professor Michael Barras's areas of expertise, story ideas and help finding experts, contact our Media team: